13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...17, 18, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-05-17
5:07 pm
Purchase
2024-05-1513GPieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P257,622
19.500%
257,622increase
(New Position)
Filing
History
2024-03-05
4:59 pm
Unchanged
2024-02-2913DMoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P21,751,284
34.600%
0
(Unchanged)
Filing
History
2024-02-22
4:45 pm
Unchanged
2024-02-2013GenGene Holdings Inc. Common Stock
ENGN
BIOTECHNOLOGY VALUE FUND L P3,196,439
7.200%
0
(Unchanged)
Filing
History
2024-02-14
10:30 am
Sale
2023-12-3113GAclaris Therapeutics, Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-3,360,941decrease
(Position Closed)
Filing
History
2024-02-14
10:28 am
Sale
2023-12-3113GRein Therapeutics Inc.
RNTX
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-236,835decrease
(Position Closed)
Filing
History
2024-02-14
10:26 am
Purchase
2023-12-3113GAnnexon, Inc.
ANNX
BIOTECHNOLOGY VALUE FUND L P7,000,000
8.900%
3,219,306increase
(+85.15%)
Filing
History
2024-02-14
10:24 am
Purchase
2023-12-3113GAravive, Inc.
ARAV
BIOTECHNOLOGY VALUE FUND L P8,164,510
9.990%
2,055,452increase
(+33.65%)
Filing
History
2024-02-14
10:22 am
Purchase
2023-12-3113GASLAN Pharmaceuticals Limited
ASLN
BIOTECHNOLOGY VALUE FUND L P5,418,122
9.990%
5,418,122increase
(New Position)
Filing
History
2024-02-14
10:20 am
Sale
2023-12-3113GBionomics Limited
BNOX
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-14,174,157decrease
(Position Closed)
Filing
History
2024-02-14
10:18 am
Purchase
2023-12-3113GCidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P463,776
9.990%
120,720increase
(+35.19%)
Filing
History
2024-02-14
10:16 am
Sale
2023-12-3113GCullinan Oncology, Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P4,393,321
9.990%
-3,115,738decrease
(-41.49%)
Filing
History
2024-02-14
10:13 am
Purchase
2023-12-3113GCentessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P8,774,570
9.000%
1,880,225increase
(+27.27%)
Filing
History
2024-02-14
10:11 am
Sale
2023-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-2,736,613decrease
(Position Closed)
Filing
History
2024-02-14
10:09 am
Purchase
2023-12-3113GCytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P6,702,889
9.990%
107,088increase
(+1.62%)
Filing
History
2024-02-14
10:08 am
Purchase
2023-12-3113GDelcath Systems, Inc.
DCTH
BIOTECHNOLOGY VALUE FUND L P2,338,426
9.990%
776,912increase
(+49.75%)
Filing
History
2024-02-14
10:06 am
Purchase
2023-12-3113GEledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P4,326,710
17.900%
2,000,000increase
(+85.96%)
Filing
History
2024-02-14
10:01 am
Purchase
2023-12-3113GElevation Oncology, Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P4,450,885
9.990%
2,138,685increase
(+92.50%)
Filing
History
2024-02-14
09:58 am
Purchase
2023-12-3113G89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P7,568,480
7.800%
4,047,354increase
(+114.94%)
Filing
History
2024-02-14
09:56 am
Unchanged
2023-12-3113G4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P4,007,413
9.400%
0
(Unchanged)
Filing
History
2024-02-14
09:54 am
Purchase
2023-12-3113GGH Research PLC
GHRS
BIOTECHNOLOGY VALUE FUND L P10,400,158
19.990%
1,125,000increase
(+12.13%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...17, 18, Next